+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biotechnology Instrumentation Market by Product, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010908
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biotechnology Instrumentation Market grew from USD 24.19 billion in 2023 to USD 26.49 billion in 2024. It is expected to continue growing at a CAGR of 9.84%, reaching USD 46.67 billion by 2030.

The biotechnology instrumentation market encompasses a broad range of analytical and diagnostic tools used in laboratories and research facilities engaged in biological studies, genetic engineering, pharmaceuticals, and medical research. These instruments include spectrometers, chromatography systems, DNA sequencers, and PCR machines. The necessity for advanced biotechnology instrumentation is propelled by the increasing demand for efficient and accurate research tools that accelerate drug development, enable personalized medicine, and improve diagnostic capabilities. Major applications span genomics, proteomics, clinical diagnostics, and environmental science, serving end-use sectors such as pharmaceutical companies, research institutes, and hospitals. Market growth is driven by advancements in technology like automation and miniaturization, heightened funding for biotechnology research, and increasing prevalence of diseases requiring sophisticated diagnostic tools. Conversely, challenges include high cost of instruments, stringent regulatory environments, and complexities in technology integration.

The market presents key opportunities in the expanding field of precision medicine and burgeoning biopharmaceutical production, where demand for sophisticated instrumentation is high. Companies can capitalize on these opportunities by investing in R&D to develop cost-effective and versatile instruments that can handle multi-disciplinary applications. Furthermore, partnerships with academic and research institutions can facilitate innovation. However, limitations such as high maintenance costs and skills shortage in handling complex instruments pose obstacles. Addressing these by offering training programs and support services may enhance market penetration. The nature of the biotechnology instrumentation market is competitive, with continuous innovation as a defining characteristic. Companies should focus on areas such as digital integration and artificial intelligence to enhance instrument functionality and data analysis. In summary, the market is ripe for growth, but navigating economic constraints and regulatory hurdles with strategic innovation and collaboration will be crucial for businesses looking to expand their footprint in biotechnology instrumentation.

Understanding Market Dynamics in the Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Continuous rise in prevalence of diseases and need for effective treatments
    • Growing adoption of portable point-of-care diagnostic devices
    • Improved healthcare spending and infrastructure across economies
  • Market Restraints
    • Initial high costs associated with implementation of biotechnology instruments
  • Market Opportunities
    • Growing advancements in lab automation instruments
    • Emerging investments in genomic research projects and startups
  • Market Challenges
    • Stringent regulatory requirements and validation processes

Exploring Porter’s Five Forces for the Biotechnology Instrumentation Market

Porter’s Five Forces framework further strengthens the insights of the Biotechnology Instrumentation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biotechnology Instrumentation Market

External macro-environmental factors deeply influence the performance of the Biotechnology Instrumentation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Instrumentation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alcon Scientific, Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Bruker Corporation, Danaher Corporation, Endress+Hauser Group Services AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., HORIBA, Ltd., Hudson Robotics, Illumina, Inc., JASCO, Lumentum Holdings Inc., Merck KGaA, Oxford Nanopore Technologies PLC, PerkinElmer U.S. LLC, Qiagen GmbH, Quest Diagnostics Incorporated, Sartorius AG, Shimadzu Corporation, Siemens Healthcare GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Instrumentation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Bioreactors
    • Centrifuges
    • Electrophoresis
    • Immunoassay
    • Incubators
    • Liquid Chromatography
    • Mass Spectrometry
    • Next Generation Sequencing
    • Spectrophotometers
  • End-User
    • Biotechnology & Biopharmaceutical Companies
    • Clinical Research Organizations (CROs)
    • Government & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Continuous rise in prevalence of diseases and need for effective treatments
5.1.1.2. Growing adoption of portable point-of-care diagnostic devices
5.1.1.3. Improved healthcare spending and infrastructure across economies
5.1.2. Restraints
5.1.2.1. Initial high costs associated with implementation of biotechnology instruments
5.1.3. Opportunities
5.1.3.1. Growing advancements in lab automation instruments
5.1.3.2. Emerging investments in genomic research projects and startups
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements and validation processes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Biotechnology Instrumentation Market, by Product
6.1. Introduction
6.2. Bioreactors
6.3. Centrifuges
6.4. Electrophoresis
6.5. Immunoassay
6.6. Incubators
6.7. Liquid Chromatography
6.8. Mass Spectrometry
6.9. Next Generation Sequencing
6.10. Spectrophotometers
7. Biotechnology Instrumentation Market, by End-User
7.1. Introduction
7.2. Biotechnology & Biopharmaceutical Companies
7.3. Clinical Research Organizations (CROs)
7.4. Government & Academic Institutes
8. Americas Biotechnology Instrumentation Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biotechnology Instrumentation Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biotechnology Instrumentation Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET RESEARCH PROCESS
FIGURE 2. BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOTECHNOLOGY INSTRUMENTATION MARKET DYNAMICS
TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 108. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biotechnology Instrumentation market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alcon Scientific
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Endress+Hauser Group Services AG
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • HORIBA, Ltd.
  • Hudson Robotics
  • Illumina, Inc.
  • JASCO
  • Lumentum Holdings Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies PLC
  • PerkinElmer U.S. LLC
  • Qiagen GmbH
  • Quest Diagnostics Incorporated
  • Sartorius AG
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Methodology

Loading
LOADING...

Table Information